MedPath

Homeopathic treatment of tumors of uterus

Phase 2
Conditions
Health Condition 1: null- Uterine fibroid
Registration Number
CTRI/2018/04/013273
Lead Sponsor
ational Institute of Homoeopathy Ministry of AYUSH Govt of India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Premenopausal women

2. Age 18-45 years

3. Uterine fibroids confirmed by pelvic and/or transvaginal ultrasonography

4. Presence of any of the symptoms such as abnormal uterine bleeding (profuse menstruation or intercyclic menstruation), pelvic heaviness, pain during menstruation, pain during intercourse, and pressure symptoms such as urinary frequency, constipation etc.

5. Patients taking oral contraceptive pills (OCPs) will be advised to stop pills till it exhaust for the ongoing cycle, followed by re-assessment of symptoms in the next cycle enrolment

6. Patients under hormonal replacement therapy (HRT) to be included after a washout period of 3 months

7. Patients with known but controlled systemic diseases with medication

8. Ability to read Bengali

9. Patients giving written consent to participate

Exclusion Criteria

1. Asymptomatic fibroids

2. Patients with calcified fibroid, coagulation disorders, extrauterine fibroid, polyp, cervical fibroid, any fibroid causing hydronephrosis, fibroid with solid ovarian mass

3. Unevaluated gynaecological abnormalities; e.g. unexplained vaginal bleeding, cervical dysplasia, pelvic inflammatory diseases (PID) within one month, patients with suspicious adenomyosis, gross developmental defect or congenital abnormalities of the uterus etc.

4. Patients with haemoglobin less than 7 gm/dl (severe anaemia)

5. Recent rapid growth of fibroid; i.e. doubling in size within last one to six months

6. Genito-urinary tract malignancy

7. Patients desiring immediate surgical management for uterine fibroid

8. Previous history of myomectomy, myolysis, uterine artery embolisation, etc., for uterine fibroids

9. Patients desiring for childbearing within next year

10.Patients insisting to use OCPs

11.Patients with psychiatric diseases

12.Pregnancy and lactation

13.Cases suffering from uncontrolled systemic illness or life-threatening infections or any vital organ failure

14.Cases already undergoing homoeopathic treatment for any chronic purpose

15.Substance abuse and/or dependence

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pelvic/transvaginal ultrasonographic measure of the fibroid(s)Timepoint: Baseline and 6 months
Secondary Outcome Measures
NameTimeMethod
Translated Bengali version of Uterine Fibroid Symptom Quality of Life questionnaire (UFS-QOL)Timepoint: Baseline, 3 months and 6 months
© Copyright 2025. All Rights Reserved by MedPath